A newly filed Form 4 shows MA Eagle II Holdings Fund, listed as an insider of MA Specialty Credit Income Fund (SCISX), made a sizable open-market purchase of the fund’s shares. The transaction, dated August 6, 2026, involved 404,694 shares acquired at $24.71 apiece, for a total outlay of $10,000,000.01. This was not a grant, … Read more
Sanofi has disclosed a substantial open-market purchase of shares in Attovia Therapeutics, Inc. (ATTO), according to a Form 4 filed with the SEC. The filing shows Sanofi bought 300,000 shares on August 6, 2026 at a price of $17.00 per share, a transaction valued at $5,100,000.00. Following the purchase, Sanofi’s stake in Attovia stands at … Read more
A newly filed Form 4 with the Securities and Exchange Commission shows Kenta Kon, President and Director of Toyota Motor Corp (NYSE: TM), purchased 85,000 shares of the automaker’s stock on August 5, 2026. The transaction was executed on the open market, meaning Kon used his own funds to acquire the shares rather than receiving … Read more
Frazier Life Sciences XI, L.P., an insider at Attovia Therapeutics, Inc. (ATTO), disclosed an open-market purchase of 588,235 shares on August 6, 2026, according to a Form 4 filed with the SEC. The shares were bought at $17.00 apiece, for a total outlay of $9,999,995.00 — a purchase sized almost exactly to the $10 million … Read more
A newly filed Form 4 with the SEC shows Paul M. Meister, an insider at Aptiv PLC (NYSE: APTV), purchased 105,631 shares of the auto-technology supplier on August 5, 2026. The trade was executed at $47.33 per share, for a total outlay of $4,999,958.88 — just shy of the $5 million mark. This was an … Read more
A Form 4 filed with the Securities and Exchange Commission shows Lim Jung Jae, CEO, Interim CFO, and a director of Reborn Coffee, Inc. (NASDAQ: REBN), reported an open-market purchase of company stock dated July 14, 2026. According to the filing, Lim acquired 131,387 shares at a stated price of $180,000.00 per share, putting the … Read more
Andrew C. Florance, the founder and chief executive officer of CoStar Group, Inc. (NASDAQ: CSGP), disclosed an open-market purchase of company stock in a Form 4 filing tied to a transaction dated August 4, 2026. Florance bought 83,300 shares at a price of $29.89 per share, a total outlay of $2,489,837.00 paid with his own … Read more
A newly filed Form 4 shows that Harrison Street Real Assets Fund LLC, identified as a 10%-plus owner of 2023 ETF Series Trust (NFRX), purchased 372,856 shares on August 4, 2026, in an open-market transaction. The insider paid $26.82 per share, bringing the total outlay to $9,999,997.92 — just shy of the $10 million mark. … Read more
A newly filed Form 4 shows Corbin Capital Partners, L.P. adding to its stake in Privacore VPC Asset Backed Credit Fund, a non-traded fund that does not carry a public ticker symbol. The filing, dated August 3, 2026, discloses an open-market purchase of 246,548 shares at $10.14 apiece, for a total outlay of $2,500,000.00. Corbin … Read more
Michael F. Mahoney, Chairman, President and CEO of Boston Scientific Corp (BSX), disclosed an open-market purchase of 186,240 shares on August 3, 2026, according to a Form 4 filing. The transaction was executed at a price of $48.33 per share, for a total outlay of $9,001,407.55 out of Mahoney’s own funds. Following the purchase, Mahoney’s … Read more
Manulife (Singapore) Pte. Ltd., a 10%+ owner of John Hancock GA Mortgage Trust, disclosed an open-market purchase of 109,925 shares on July 31, 2026, according to a Form 4 filing. The transaction was priced at $18.19 per share, for a total outlay of $1,999,967.57. This was a purchase made with the insider’s own capital rather … Read more
A new Form 4 filing shows Space Summit Capital LLC, listed as an insider of East West Ave Acquisition Corp. (EWAV), purchased 1,087,000 shares of the company on July 31, 2026. The transaction was an open-market purchase, meaning the buyer used its own capital rather than receiving shares through options, grants, or other compensation arrangements. … Read more